# Effects of TNF Blockade on Human BPH/LUTS

> **NCT06062875** · PHASE2 · RECRUITING · sponsor: **Endeavor Health** · enrollment: 70 (estimated)

## Conditions studied

- Benign Prostatic Hyperplasia (BPH)

## Interventions

- **DRUG:** Adalimumab

## Key facts

- **NCT ID:** NCT06062875
- **Lead sponsor:** Endeavor Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-24
- **Primary completion:** 2028-04-01
- **Final completion:** 2028-06-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2024-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06062875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06062875, "Effects of TNF Blockade on Human BPH/LUTS". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06062875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*